Search Results - "Simpson, Carrie A"

In vivo toxicity, biodistribution, and clearance of glutathione-coated gold nanoparticles by Simpson, Carrie A., PhD, Salleng, Kenneth J., DVM, Cliffel, David E., PhD, Feldheim, Daniel L., PhD

“…Abstract Gold nanoparticles are emerging as promising materials from which to construct nanoscale therapeutics and therapeutic delivery systems. However,…”
Get full text

Short-Chain PEG Mixed Monolayer Protected Gold Clusters Increase Clearance and Red Blood Cell Counts by Simpson, Carrie A, Agrawal, Amanda C, Balinski, Andrzej, Harkness, Kellen M, Cliffel, David E

“…Monolayer-protected gold nanoparticles have great potential as novel building blocks for the design of new drugs and therapeutics based on the easy ability to…”
Get full text

Development of a SARS-CoV-2 Vaccine Candidate Using Plant-Based Manufacturing and a Tobacco Mosaic Virus-like Nano-Particle by Royal, Joshua M., Simpson, Carrie A., McCormick, Alison A., Phillips, Amanda, Hume, Steve, Morton, Josh, Shepherd, John, Oh, Youngjun, Swope, Kelsi, DeBeauchamp, Jennifer L., Webby, Richard J., Cross, Robert W., Borisevich, Viktoriya, Geisbert, Thomas W., Demarco, Jennifer K., Bratcher, Barry, Haydon, Hugh, Pogue, Gregory P.

“…Stable, effective, easy-to-manufacture vaccines are critical to stopping the COVID-19 pandemic resulting from the coronavirus SARS-CoV-2. We constructed a…”
Get full text

Gastrointestinal Bioavailability of 2.0 nm Diameter Gold Nanoparticles by Smith, Candice A, Simpson, Carrie A, Kim, Ganghyeok, Carter, Carly J, Feldheim, Daniel L

“…The use of gold nanoparticles as imaging agents and therapeutic delivery systems is growing rapidly. However, a significant limitation of gold nanoparticles…”
Get full text

Unexpected Toxicity of Monolayer Protected Gold Clusters Eliminated by PEG-Thiol Place Exchange Reactions by Simpson, Carrie A, Huffman, Brian J, Gerdon, Aren E, Cliffel, David E

“…Monolayer protected clusters (MPCs) are small, metal nanoparticles capped with thiolate ligands that have been widely studied for their size-dependent…”
Get full text

Reproducibility and flexibility of monoclonal antibody production with Nicotiana benthamiana by Swope, Kelsi, Morton, Josh, Pogue, Gregory P, Burden, Leigh, Partain, Nicholas, Hume, Steve, Shepherd, John, Simpson, Carrie A, Brennan, Miles B, Furman, Thomas C, Kingrey-Gebe, Sheila, Martinez, Theresa, McDonough, Jim, Pauly, Michael H, Whaley, Kevin J, Zeitlin, Larry, Bratcher, Barry, Haydon, Hugh

“…The ongoing SARS-CoV-2 coronavirus pandemic of 2020-2021 underscores the need for manufacturing platforms that can rapidly produce monoclonal antibody (mAb)…”
Get full text

Tiopronin Gold Nanoparticle Precursor Forms Aurophilic Ring Tetramer by Simpson, Carrie A, Farrow, Christopher L, Tian, Peng, Billinge, Simon J. L, Huffman, Brian J, Harkness, Kellen M, Cliffel, David E

“…In the two step synthesis of thiolate-monolayer protected clusters (MPCs), the first step of the reaction is a mild reduction of gold(III) by thiols that…”
Get full text

CoV-RBD121-NP Vaccine Candidate Protects against Symptomatic Disease following SARS-CoV-2 Challenge in K18-hACE2 Mice and Induces Protective Responses That Prevent COVID-19-Associated Immunopathology by DeMarco, Jennifer K, Royal, Joshua M, Severson, William E, Gabbard, Jon D, Hume, Steve, Morton, Josh, Swope, Kelsi, Simpson, Carrie A, Shepherd, John W, Bratcher, Barry, Palmer, Kenneth E, Pogue, Gregory P

“…We developed a SARS-CoV-2 vaccine candidate (CoV-RBD121-NP) comprised of a tobacco mosaic virus-like nanoparticle conjugated to the receptor-binding domain of…”
Get full text

Nanoscale Structure–Activity Relationships, Mode of Action, and Biocompatibility of Gold Nanoparticle Antibiotics by Bresee, Jamee, Bond, Constance M, Worthington, Roberta J, Smith, Candice A, Gifford, Jennifer C, Simpson, Carrie A, Carter, Carly J, Wang, Guankui, Hartman, Jesse, Osbaugh, Niki A, Shoemaker, Richard K, Melander, Christian, Feldheim, Daniel L

“…The emergence of resistance to multiple antimicrobial agents by pathogenic bacteria has become a significant global public health threat. Multi-drug-resistant…”
Get full text

Gold nanoparticles to improve HIV drug delivery by Garrido, Carolina, Simpson, Carrie A, Dahl, Noelle P, Bresee, Jamee, Whitehead, Daniel C, Lindsey, Erick A, Harris, Tyler L, Smith, Candice A, Carter, Carly J, Feldheim, Daniel L, Melander, Christian, Margolis, David M

“…Antiretroviral therapy (ART) has improved lifespan and quality of life of patients infected with the HIV-1. However, ART has several potential limitations,…”
Get full text

A Structural Mass Spectrometry Strategy for the Relative Quantitation of Ligands on Mixed Monolayer-Protected Gold Nanoparticles by Harkness, Kellen M, Hixson, Brian C, Fenn, Larissa S, Turner, Brian N, Rape, Amanda C, Simpson, Carrie A, Huffman, Brian J, Okoli, Tracy C, McLean, John A, Cliffel, David E

“…It is becoming increasingly common to use gold nanoparticles (AuNPs) protected by a heterogeneous mixture of thiolate ligands, but many ligand mixtures on…”
Get full text

Manufacturing plant-made monoclonal antibodies for research or therapeutic applications by Swope, Kelsi, Morton, Josh, Pogue, Gregory P, Hume, Steve, Pauly, Michael H, Shepherd, John, Simpson, Carrie A, Bratcher, Barry, Whaley, Kevin J, Zeitlin, Larry, Davis, Keith R, Haydon, Hugh

“…Monoclonal antibodies (mAbs) hold great promise for treating diseases ranging from cancer to infectious disease. Manufacture of mAbs is challenging, expensive,…”
Get more information

In vivo testing for gold nanoparticle toxicity by Simpson, Carrie A, Huffman, Brian J, Cliffel, David E

“…A technique for measuring the toxicity of nanomaterials using a murine model is described. Blood samples are collected via submandibular bleeding while urine…”
Get more information

Reproducibility and flexibility of monoclonal antibody production with Nicotiana benthamiana by Swope, Kelsi, Morton, Josh, Pogue, Gregory P., Burden, Leigh, Partain, Nicholas, Hume, Steve, Shepherd, John, Simpson, Carrie A., Brennan, Miles B., Furman, Thomas C., Kingrey-Gebe, Sheila, Martinez, Theresa, McDonough, Jim, Pauly, Michael H., Whaley, Kevin J., Zeitlin, Larry, Bratcher, Barry, Haydon, Hugh

“…The ongoing SARS-CoV-2 coronavirus pandemic of 2020-2021 underscores the need for manufacturing platforms that can rapidly produce monoclonal antibody (mAb)…”
Get full text